Product Details
SERETIDE 50MCG/250MCG DISKUS INHALATION POWDER
Fluticasone Propionate; Salmeterol (Salmeterol Xinafoate)250 mcg/Metered-Dose; 50 mcg/Metered-Dose
Inhalation powder
ROA
Inhalation
Applicant Name
GlaxoSmithKline Pharmaceutical Nig. PLC (GSK)
NRN
04-3323
Status
Active
ATC Code
R03AK06
Product Category
Drugs
Marketing Category
Prescription-only Medicine (POM)
Packsize
1*60
Product Description
SERETIDE 50MCG/250MCG DISKUS INHALATION POWDER SALMETEROL AND FLUTICASONE PROPIONATE (Active Ingredients - Salmeterol (as xinafonate) 72.5µg & Fluticasone propionate 250µg) (Other ingredients- Lactose Monohydrate - 12.5mg) Apr-23 Drugs Imported Products 1*60 Prescription Only Medicine (POM) 02/03/2020 GLAXOSMITHKLINE PHARMACEUTICAL NIGERIA LTD., INDUSTRIAL AVENUE ILUPEJU LAGOS 12711000 delphine.u.onyeaso@gsk.com GlaxoSmithKline LLC,1011 North Arendell Avenue,Zebulon ,North Carolina USA, GlaxoSmithKline LLC,1011 North Arendell Avenue ,Zebulon,North Carolina USA, United States
Manufacturer Name
GlaxoSmithKline LLC
Manufacturer Country
UNITED STATES OF AMERICA
Approval Date
2023-07-06
Expiry Date
2028-07-05